Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Targeted Drug Delivery
100%
Nanocapsule
100%
Monoclonal Antibody
33%
Trastuzumab
33%
Methotrexate
33%
Farletuzumab
33%
Triple Negative Breast Cancer
22%
Receptor Protein
11%
Mortality Rate
11%
Mouse Model
11%
Scanning Electron Microscopy
11%
Progesterone Receptor Positive Breast Cancer
11%
Estrogen Receptor
11%
Cytotoxicity
11%
Biosimilar Agent
11%
Folate Receptor 1
11%
Neoplasm
11%
Endocrine Therapy
11%
Medicine and Dentistry
Nanocapsule
100%
Breast Cancer
100%
Cancer Types
33%
Trastuzumab
33%
Farletuzumab
33%
Monoclonal Antibody
33%
Methotrexate
33%
In Vitro
22%
Triple Negative Breast Cancer
22%
Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy
11%
Electrospray Ionization
11%
Lymph Node
11%
Neoplasm
11%
Hormone Therapy
11%
Biosimilar
11%
Mortality Rate
11%
Folate Receptor 1
11%
Scanning Electron Microscopy
11%
Confocal Laser Scanning Microscopy
11%
Cytotoxicity
11%
Progesterone Receptor Positive Breast Cancer
11%
Xenograft
11%
Receptor Protein
11%
Estrogen Receptor
11%